BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,333,000 | +22.0% | 2,583,840 | -0.7% | 0.00% | +50.0% |
| Q3 2019 | $2,731,000 | +2.7% | 2,601,064 | +66.2% | 0.00% | 0.0% |
| Q2 2019 | $2,660,000 | -20.0% | 1,564,959 | +58.7% | 0.00% | -33.3% |
| Q1 2019 | $3,323,000 | +151.6% | 985,959 | +118.0% | 0.00% | +200.0% |
| Q4 2018 | $1,321,000 | +91.4% | 452,233 | +329.9% | 0.00% | – |
| Q2 2018 | $690,000 | 0.0% | 105,200 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $690,000 | -75.4% | 105,200 | -53.7% | 0.00% | -75.0% |
| Q1 2017 | $2,804,000 | +148.4% | 227,200 | +174.1% | 0.00% | +100.0% |
| Q4 2016 | $1,129,000 | – | 82,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |